Clinical Trials

Upcoming Clinical Trials

A first-line dose-escalation study of SBP-101 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is currently enrolling patients.

Click here for more information regarding the Phase 1 study of SBP-101 in the United States.

Click here for more information regarding the Phase 1 study of SBP-101 in Australia.

Completed Clinical Trials

The First-in-Human Phase 1 study of SBP-101 in patients with pancreatic ductal adenocarcinoma has reached completion in Australia and the United States. 

Click here for summary of study results.